Quarterly report pursuant to Section 13 or 15(d)

Fair Value Disclosures (Other Financial Instruments) (Details)

v3.19.3
Fair Value Disclosures (Other Financial Instruments) (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 02, 2019
May 04, 2019
Nov. 03, 2018
Aug. 04, 2018
Nov. 02, 2019
Nov. 03, 2018
Feb. 02, 2019
Fair Value Disclosures [Abstract]              
Total debt, excluding unamortized debt issuance costs, finance leases and note payable, Fair Value $ 2,993,000,000   $ 3,157,000,000   $ 2,993,000,000 $ 3,157,000,000 $ 2,579,000,000
Total debt, excluding unamortized debt issuance costs, finance leases and note payable, carrying amount 4,198,000,000   4,303,000,000   4,198,000,000 4,303,000,000 $ 3,856,000,000
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of long-lived assets impaired, fair value disclosure   $ 22,000,000 72,000,000     72,000,000  
Asset Impairment Charges 0 14,000,000 0 $ 52,000,000 0 52,000,000  
Carrying value of right-of-use assets impaired, fair value disclosure   58,000,000          
Right-of-use assets, fair value disclosure   19,000,000          
Fair Value, Concentration of Risk, Investments $ 0       $ 0    
Fair Value, Inputs, Level 2 [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Assets, Fair Value Disclosure   8,000,000 $ 20,000,000     $ 20,000,000  
Restructuring and management transition [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Asset Impairment Charges   $ 14,000,000